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Abstract 
 
Air sampling and biological sampling have been performed to examine the exposure to 
nicotine in the Nicorette patch and Nicorette gum production at Pfizer Health AB in 
Helsingborg, Sweden. For this purpose stationary and personal sampling equipment have 
been used. At the Nicorette patch production, XAD-2 tubes were used to sample nicotine 
vapor and at the Nicorette gum production Teflon filters were used to sample the 
Nicotine Resin Complex 20% IRP (NRC) in the air. NRC is an ion exchange resin that 
carries the nicotine in the Nicorette gums. Specimens of urine from the presumably not 
exposed employees, from another source than at in the Nicorette production room, have 
been examined into the concentration of cotinine, a primary metabolite to nicotine. 
Cotinine is a reliable substance of measuring the exposure to nicotine.  
 
For the nicotine vapor extraction, a slightly modified NIOSH’s method NMAM-2544 has 
been used. The extraction of nicotine from the NRC and the Teflon filters was done with 
Pfizer’s method NM-080-3 and an extra liquid-liquid nicotine extraction has been done as 
well. The same program, in a liquid chromatograph with tandem mass spectrometry (LC-
MS/MS), was used for analyzing both the nicotine from the NRC and the nicotine vapor.  
 
The specimens of urine were worked up and the urinary cotinine was isolated and 
transferred to an organic phase and analyzed in an LC-MS/MS.  
 
The average concentration of nicotine in the ambient air in the Nicorette patch 
manufacturing room is low, 2 µg/m3. But at the reception position, where the employees 
collect the Nicorette patches, the concentration of nicotine is 30 µg/m3 on average. An 
average of the estimated nicotine exposure, based on the concentration of nicotine in the 
air samples for the employees, is 70 µg*h/m3. It is also very obvious, from the urinary 
cotinine analysis, that there are persons who are exposed to more nicotine than from the 
nicotine vapor. This may be due to the fact that nicotine has penetrated through the skin 
when the employees have not used sufficient protection clothes.  
 
In the Nicorette gum production room, the concentration of nicotine in the air for a whole 
working day is measured to an average value of 4 µg/m3, which is equal to 20 µg/m3 of 
NRC. The employees are exposed to the irritating NRC dust, which has on average a 
concentration of 35 µg/m3 of nicotine, which equals 175 µg/m3 of NRC. That gives an 
estimated average exposure of 90 µg*h/m3 of nicotine, which equals 450 µg*h/m3 of 
NRC, which comes from the nicotine measured in the air samples. The exposure is very 
well connected to the working procedures. In the Nicorette gum production site, the 
concentration of cotinine varied very much in relation to the amount of nicotine that the 
employees were exposed to from the air.  
 
The NRC is very irritating and affects the upper respiratory region and causes coughs and 
sour throats. Irritation from the NRC is noticed in concentrations in the range from 13 
µg/m3 up to 600 µg/m3. Measured in the concentration of nicotine, the range of the level, 
in which the irritation is noticed, corresponds to between 2.5 and 120 µg/m3. That is 
many times lower than the stated Threshold Limit Value (TLV) for nicotine, 500 µg/m3.  
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A Introduction 
A.1 Assignment 
Pfizer Health AB, earlier Pharmacia and Upjohn has for the well-being and health of the 
employees and the environment tried to reduce sources of misconditions, pollutants and 
other factors that can cause any damage or injuries.  
 
At the Nicorette patch and Nicorette gum production the employees are exposed to 
nicotine in the first phase of the manufacturing process. In the Nicorette patch production 
the exposure comes from nicotine vapor in the air and nicotine in the Nicorette patches, 
which are carried by hand. In the Nicorette gum production the exposure comes from the 
Nicotine Resin Complex 20% IRP (NRC). NRC is very dusty and irritates the employees 
when the NRC dust is inhaled in the production room. The NRC is used to carry 
unreacted nicotine and control the release of it when the Nicorette gums are chewed. 
 
To examine the exposure of the employees, nicotine was sampled and measured in the air 
of the manufacturing rooms. The analysis of nicotine was done in a liquid 
chromatographic system with tandem mass spectrometric detection (LC-MS/MS). 
Cotinine was extracted from specimens of urine and analyzed in the LC-MS/MS, as well.  
 
To be certain that the urinary cotinine comes from the exposure when manufacturing the 
Nicorette products, the employees had to be presumably not be exposed to nicotine 
during the study. A questionnaire was filled in every day during the participation in the 
study and the employees wrote down if they had been exposed to nicotine the days before 
and during their involvement in the research. In the questionnaire they also filled in their 
working tasks and the time used for the sampling of the nicotine. 
 
Nine persons from the Nicorette patch production were participating in the study during 
three weeks. In the Nicorette gum production, seven persons participated for two weeks. 
 
A.2 Aim 
The aim of this diploma work is to study the exposure to nicotine for the employees in 
the production of Nicorette patch and Nicorette gum at Pfizer Health AB.  
 
The study investigates the correlation between the nicotine content in the surrounding air 
and the urinary cotinine in both the Nicorette Patch and the Nicorette Gum production. 
The correlation may show if the exposure only comes from the air breathed, or if there is 
also the dermal route of exposure.  
 
In the Nicorette Gum production, air samples of the NRC were investigated in order to 
determine the concentration that causes irritation in the respiratory region.  
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A.3 General information of nicotine 
A.3.1 Exposure to nicotine 
Nicotine has been used for a very long time as a drug and today tobacco is one of the 
most widely spread and used drugs in the world. Nicotine is an alkaloid found in many 
plants such as the potato, the tomato, the green pepper and of course the tobacco plants 
Nicotiana tabacum and Nicotiana rustica. The tobacco leaf usually contains from 1 to 3 
% of nicotine. The biosynthesis takes place in the roots and nicotine is then accumulated 
in the leaves. [1, 2] 
 
The most common ways of nicotine absorption are through the lungs, the skin and the 
oral cavity, but it can be absorbed, though very poorly, through the gastrointestinal tract 
and reabsorbed through the urinary bladder. Nicotine is dibasic and has two pKa of 3.04 
and 7.84, at 25 degrees Celsius. The more basic a solution of nicotine, the more neutral 
the nicotine becomes and it can in a neutral state easily cross biological membranes. [2] 
 
 
A.3.2 Metabolism of nicotine 
Nicotine is metabolized in the body with phase I and phase II metabolisms. Phase I 
involves C-oxidation, N-oxidation and N-methylation. Phase II metabolism of nicotine 
involves O- and N-glucuronidation. Approximately 70-80% of the nicotine is phase I 
metabolized to cotinine in a C-oxidation, with the intermediary products 5’-
hydroxynicotine and nicotine iminium ion. Nicotine metabolizes fast in the body, it has a 
half-life of 1-2 hours. Cotinine has a longer half-life than nicotine, 15-20 hours, and can 
therefore be used as a biomarker for nicotine exposure. The enzymes that are involved in 
the metabolism of nicotine to cotinine are the cytochrome P-450 (CyP) and aldehyde 
oxidase. Especially the enzyme CyP2A6 is involved in the metabolism of nicotine to 
cotinine. In humans there is a genetic polymorphism in the CyP2A6. The variations of the 
different CyP2A6 genes have shown different enzymatic activities. Cotinine and nicotine 
continue the formations of other substances, using the other phase I or phase II 
metabolisms. The different enzymatic activities affect the result of the total sum of the 
final molecules. For a human, the individual formation of cotinine varies and can differ 
even from the approximate formatted value. [2, 3, 4]  
 
 
                                                              
CyP 
  Nicotine                      Cotinine 
Aldehyde 
oxidase 
 
 
Figure A.1: Nicotine metabolizes by a phase I metabolism, C-oxidation, to cotinine, by the enzymes 
cytochrome P-450 and aldehyde oxidase in two steps. 
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A.3.3 Effects of nicotine 
After nicotine has entered the body either through the lungs, the skin, the mouth or 
another way, it solves in the plasma and reaches the whole body quickly. Nicotine crosses 
the blood-brain barrier very easily, as well. Nicotine interacts with the nicotinic 
cholinergic receptors, which are found in the brain, the autonomic ganglia and in the 
neuromuscular junctions. In the brain there are different nicotinic receptors that vary in 
the agonist binding sites and the electrophysiological responses to stimulation. That can 
be one reason why the effects of nicotine vary. Prolonged exposure to nicotine gives 
more nicotinic receptors. The effect of an activation of the nicotinic receptor by nicotine 
is the release of neurotransmitters including acetylcholine, beta-endorphin, dopamine, 
glutamate, norepinephrine, serotonin and others. The addiction to nicotine that arises 
physiologically is strongly linked to the release of dopamine in the reward centers. [2, 3] 
 
The effects of the nicotine vary depending on the dose of nicotine the exposure consists 
of. The effects are always very fast whether it is a low or a strong dose. A strong dose of 
exposure may cause a burning sensation of the upper respiratory tract, abdominal pain, 
nausea, vomiting and diarrhea. Other effects are headache, sweating, dizziness, hearing 
and sight disturbances, confusion, weakness and incoordination. The heart may beat 
irregularly or even stop. Trembling and convulsions, faintness, shortness of breath and 
collapse may occur, which can cause death from respiratory paralysis. [5] If a low dose of 
nicotine is used regularly (for example smoking) other effects will occur. Positive 
reinforcements like relaxation, improved concentration, improved cognitive functions and 
improved mood will appear. Side effects will drastically come as a result as the 
concentration of nicotine in the plasma lowers. The negative effects appear as symptoms 
such as nervousness, irritability, anxiety, impaired concentration and impaired cognitive 
functions. The nicotine increases the blood pressure and the heart rate too. [3] 
 
After and during exposure to nicotine there is a development of tolerance. The dose to 
give the same effect from the nicotine must be stronger when the exposure is repeated. 
Tolerance develops as well as for other effects, like the cardiovascular and the toxic ones. 
The heart rate acceleration lowers when smoking regularly and the toxic effects 
(dizziness, headache and vomiting for example) disappear. [3] 
 
Nicotine is very toxic in the cells. Studies have shown that nicotine in rats have resulted 
in less free radical scavenging enzymes, which are superoxide dismutase, catalase and 
glutathione reductase. A decrease in these enzymes results in increased generation of 
superoxide anion and hydrogen peroxide, which results in higher levels of hydroxyl free 
radicals. Other studies that investigated the influence nicotine on the apoptosis showed 
that overall the apoptosis was inhibited by nicotine. The effect from nicotine on the 
proliferation showed results that nicotine stimulates the proliferation. This potential 
together with the potential of the inhibition of apoptosis make the nicotine a candidate for 
being a carcinogen. In a couple of studies nicotine has even shown a genotoxic potential 
and a potential of affecting the gene expression. [2] 
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A.4 Analysis 
Separations in a high performance liquid chromatograph (HPLC), like in other 
chromatographic separation equipments, use the equilibrium of the analyte between the 
mobile and the stationary phase. In the liquid chromatograph (LC), the mobile phase is a 
liquid. Different molecules and substances have different affinities to the mobile and to 
the stationary phases compared to the other substances. The more affinity the substance 
has for the stationary phase the longer time (retention time) it stays in the column. 
Because of the variations of time in the column, the different substances separate. The 
reversed phase LC has a water-based liquid and the stationary phase consists of 
hydrocarbon groups that are covalently bound to silica spheres. [6, 7] 
 
The detection of the substances in a mass spectrometer (MS) is carried out first by the 
separation of a difference between the mass over charge (m/z) for the substances. From 
the column the mobile phase with analytes enters the MS. An ion source, electrospray 
ionization ionizes the analytes. They are ionized because of the high potential, several 
kilovolts, between the capillary needle at the end of the column and at the entrance of the 
MS. Small droplets are formed when the sample solution is pumped into the space 
(between the capillary needle and the MS) with atmospheric pressure where the electrical 
potential is. The mobile phase and the solvent are vaporized from the droplets, the more 
they vaporize, the higher the surface potential in the droplet gets. In the droplet the 
charge density increases due the decreasing size of the droplet, until the charge is too 
high for the surface tension to keep the droplet together. When the surface potential 
becomes too high the droplet explodes in a coulomb explosion1. Smaller charged droplets 
are formed and this process continues until all of the mobile phase and solute have 
vaporized. [6, 7] 
 
The analytes separate in the first quadrupole by the first m/z that is pre-adjusted. In the 
second quadrupole, nitrogen gas flows over the substances that have passed the first 
quadrupole. They collide with nitrogen gas and fragmentize. The third and last 
quadrupole has another m/z adjusted to separate one new fragment and only that 
fragment will pass through and reach the detecting instrument. The last fragmentation is 
characteristic for just that particular analyte, which is expected. [6, 7] 
 
A.5 Measurement 
To compare the concentration of nicotine from the air and the concentration of cotinine in 
the urine a few assumptions have to be made. First of all the individual amount of air 
inhaled differs a lot. A male person, when performing the work at the Nicorette patch and 
the Nicorette gum production inhales every hour between 0.5 m3 and 1.5 m3 of air and a 
woman at the same production site inhales between 0.4 m3 and 1.3 m3 of air per hour. 
The big differences are due to the individual body sizes, the varying ways of breathing, 
the amount of work performed that very hour or just specific work positions. [8] 
 
                                                 
1 Coulomb explosion – a droplet’s surface potential is higher than its surface tension, which makes the 
uniting forces of the droplet smaller than the forces repelling each other and thus the droplet bursts. 
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The other assumptions are that the metabolism of nicotine (chapter A.3.2) to the 
biomarker, cotinine, and the rate of the renal secretion of cotinine are the same for all the 
employees. Corrections to the concentration of cotinine can be done as well as to 
compensate for the dilution of the urine as for the rate of secretion. 
 
Urine can be differently diluted. It varies because of varying water, food, coffee intake, 
exercise and many other factors. A correction to the density may therefore be necessary 
in order to measure and compare the unit of weight of the urinary substances instead of 
comparing their unit of volume.  
 
Another correction for urine is the comparison to the concentration of urinary creatinine2. 
Creatinine can be used as a comparable substance to other urinary substances. To use the 
urinary concentration of creatinine for an adjustment, the substance measured has to be 
secreted the same way as creatinine. For example food and exercise can effect the 
concentration of creatinine in the urine. Between the sexes there is always a difference, 
men secret up to three times more creatinine than women. The urinary concentration of 
creatinine cannot be used without risks of errors and miscalculations of the results.  
 
Studies of the half-life of cotinine in the body show that it is sometimes better to use the 
concentration of cotinine right as it is instead of correcting the concentration of creatinine 
or the urinary density [9]. 
 
A.6 Internal standard 
The same amount of the specific internal standard (IS) is added to every unknown sample 
and every calibration standard sample of each of the three different analytical series3. For 
the analytical series of nicotine, tri-deuterium nicotine has been used as IS and for the 
analytical series of cotinine, the IS tri-deuterium cotinine has been used. The use of IS is 
done in order to compensate for the possible losses of material when the samples are 
prepared, as well as to make it possible to measure the right concentrations as the 
capability of the analytical apparatus is not good enough to give the exact reproduction 
results. 
 
                                                 
2 Creatinine – creatine in muscles, for example, is degradable to its cyclic amide creatinine in the body at a 
constant rate. It is not reabsorbed in the tubuli of the kidneys and secreted by urine as urinary creatinine at a 
constant rate as well. 
3 The analytical series are Nicotine vapour, Nicotine Resin Complex 20% IRP and Cotinine. 
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B Nicorette production 
B.1 Nicorette patch 
In the Nicorette patch production employees work in three shifts. The shifts are divided 
into five morning shifts, 6 a.m. to 2 p.m. from Monday to Friday. The working hours 
afternoon- and night shifts are from 2 p.m. to 10 p.m. or from 10 p.m. to 6 a.m. The 
afternoon- and night shifts extend from Monday afternoon or Monday evening to 
Thursday evening or Friday morning, four working days. When necessary for the 
production, weekends are also used to satisfy order intakes. The employees rotate their 
places in the shifts. Normally they work one week morning, one week afternoon and one 
week night, before they work the morning shift again. The rotation between positions 
during the week shift in the production of Nicorette patch is also done continuously, on a 
daily basis.  
 
 
B.1.1 Exposure to the nicotine vapor 
 
Exposure of the nicotine is only studied in the “coating room”4, because that is where the 
uncovered nicotine is handled. When the bottle of liquid nicotine is handled a mask with 
airflow over the face, is worn. An apron and extra thick protection gloves, of plastic 
rubber are also worn during this moment. The 1-liter-bottle with nicotine is put into a box 
with a constant nitrogen gas flow that 
keeps the nicotine vapor from entering 
the production room. The presence of the 
nitrogen gas also makes sure that the 
oxygen contents inside the box remain 
low.  
 
Nitrogen overpressure is present in other 
parts of the manufacturing process to 
keep out oxygen. The free nicotine easily 
oxidizes in air. Other parts in the 
production are not fully covered from the 
surrounding room. Consequently 
nicotine vapor can easily enter the 
coating room.  
 
The employees are exposed to nicotine 
when they perform other tasks as well; 
most of the exposure comes from when 
they receive the Nicorette patches, at the 
reception position (picture B.1). At the 
reception an employee collects the 
Nicorette patches and stacks them on a 
                                                 
4 The coating room – the room in the Nicorette patch pro
the Mark Andy machinery. 
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room, at the Nicorette patch production, 
with the view from the reception position. 
Stationary sampling was done right over 
this position in the breathing zone. duction where Nicorette patch is manufactured in 
perforated bench, with air extraction. Another employee carries the stacks of Nicorette 
patches by hand from the reception at the Mark Andy5 (picture B.1) machinery to another 
air extracted, perforated bench. On that bench the Nicorette patches are marked and 
wrapped in aluminum foil. 
 
Overall ventilation is run all the time, three large overall air extraction regulators are 
situated in the ceiling just above the Mark Andy. If the ventilation is interrupted or 
drastically lowers warning indicators give notice. 
 
During these moments in the production of Nicorette patch, the LIF-clothes6 and double 
layers of protection gloves are worn. [10]  
 
B.2 Nicorette gum 
The production in the Nicorette gum manufacturing as well as in the Nicorette patch 
production is divided into shift work. The shifts are divided into three, two shifts daytime 
and a constant night shift. The morning shift extends from 6 a.m. until 2 p.m., Monday to 
Friday, the afternoon shift, Monday to Thursday 2 p.m. until 10 p.m. and the night shift 
starts after the afternoon shift Monday night for eight hours and finishes Friday morning 
6 a.m. Production does often take place during weekends too, if order intakes make it 
necessary. The employees have one morning shift and one afternoon shift every second 
week. The employees that work night shift always work night. Like in the Nicorette patch 
production, the changing 
of working positions is 
also done continuously, 
from day to day, to vary 
the workload during the 
week shift.  
 
The mixing of NRC is 
done in a cupboard behind 
a transparent plastic door 
and with the use of a pair 
of thick plastic protection 
gloves, a glove box, see 
picture B.2. The design of 
the glove box makes it 
possible to handle the 
open bag containing the 
NRC safely. Inside the 
glove box there is a 
perforated steel bench 
Figure B.2: The glove box where the NRC is filled into the 
container below. The glove box has a perforated bench with air 
extraction.  
                                                 
5 Mark Andy – the brand of the machine that processes the manufacturing of the Nicorette patch. 
6 LIF-clothes are protection clothes that are used in the clean production area. The LIF-clothes consist of a 
cap (single use) which covers hair and ear, a vest, trousers and socks that are used up to one day, depending 
of the contamination, and slippers.  
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with air extraction. There is a big hole in the bench, which leads down into the container 
for mixing the NRC. Between the container and the bench there is a sieve, which 
prevents the powder from clustering.  
 
The room where the premix, the mixing room7, is manufactured is ventilated with a few 
point extractions in the walls and four large overall air extractions in the ceiling. There 
are two central vacuum cleaners in the room for cleaning. 
 
 
B.2.1 Exposure to Nicotine Resin Complex 20% IRP 
Exposure to the NRC occurs during the preparing of the premix batch8 of Nicorette gum. 
In this mixing activity the components, which are also in powder condition, fill the room, 
which becomes more or less dust-laden. 
 
When the container below the sieve is filled with the NRC, it is made to only contain the 
NRC, it dusts and the exposure to the NRC occurs. Other exposure occurs when the NRC 
is emptied into the premix container 
(picture B.3). Because of the NRC’s 
tendency to dust when emptied into 
the premix-container, consequently 
the less content in the container the 
less dust. Although most of the 
employees use the container for 
filling it with the other Nicorette 
gum ingredients, sodium carbonate, 
sodium bicarbonate, acesulfame K 
and magnesium oxide, with the 
NRC. Then the room quickly 
becomes very dust-laden and 
severe irritation occurs.   
 
 
 
Very rarely exposure of the NRC 
occurs when the premix is emptied 
into the warm chamber, where the 
Nicorette gum components, 
including the liquid menthol are 
mixed together. All of the gum 
components above mentioned and 
xylitol, may dust through the not 
totally sealed joint, between the 
                                                 
Figure B.3: The premix container where the 
Nicorette gum ingredients, in powder condition, are 
mixed. 
7 The mixing room – the room where the components of the Nicorette gums are mixed together to the 
premix batch. 
8 Premix batch – the result from the first mixing of the Nicorette gum powder ingredients; acesulfame K, 
magnesium oxide, Nicotine Resin Complex 20% IRP, sodium bicarbonate and sodium carbonate.  
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premix container and the tube to the chamber below. The following mixing process takes 
place at the floor below the mixing room, where no exposure to nicotine occurs. 
 
The employees wear the LIF-clothes and as usual when handling the NRC, a mask9 as 
well. 
 
 
C Methods  
C.1 Nicotine 
C.1.1 Nicotine vapor 
C.1.1.1 Nicotine vapor sampling procedure 
The air sampling was done with nicotine absorbent, XAD-2 sorbent sample cartridges 
(SKC Tube XAD-2), containing an Amberlite resin, which easily absorbs organic 
compounds. The XAD-2 cartridge was attached to an air-blowing pump (MSA, Escort 
ELF Pump, Aver or SKC, Aircheck sampler model 224-52) with a rubber hose (Latex 
tubing, Amber, VWR Scientific).  
 
The XAD-2 cartridges were attached at the level of breathing, the breathing zone10, on 
the shoulder of the employees. The pumps, which suck around one liter of air per minute 
through the XAD-2 tube, were running while the employees worked inside the coating 
room.  
 
Other pumps were installed in the room at different places to measure the amount of 
nicotine content in the ambient air in the coating room. One pump was placed right over 
the bench where the Nicorette patches were received and collected. Another pump was 
placed either by a wall a couple of meters away from the Mark Andy, or it was placed by 
the doors of the room, as well as a couple of meters from the Mark Andy. One 
measurement was done in direct contact with the Mark Andy, by the waste roll. All the 
XAD-2 cartridges attached to these pumps were placed in the breathing zone. All 
sampling was done with an air-blow of around one liter per minute. (Figure A.5.1 – Map 
of the coating room, Appendix 5) 
 
The air samples that were collected in the coating room for Nicorette patch, were marked 
and stored for a maximum of 4 weeks at -20 degrees Celsius, depending on when the 
samplings were done.  
 
C.1.1.2 Extraction of nicotine from the XAD-2 and sample preparation 
First the cartridges were sawed and cracked to collect the glass wool and the Amberlite 
resin. Nicotine was extracted from the Amberlite resin with ethyl acetate (Lab-Scan 
Analytical Sciences) [11]. The glass wool and the resin were put into 5 ml glass test 
                                                 
9 Mask – the mask is a mask covering the mouth and nose made to protect the respiratory region from dust. 
10 Breathing zone – the area around the head of a person standing in an upright position.  
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tubes. 1.9 ml of ethyl acetate and 0.1 ml of internal standard (IS) tri-deuterium nicotine 
(Lab-Scan Analytical Sciences) in ethyl acetate with the concentration of 10 µg/ml, were 
added. The test tubes were shaken vigorously for 30 minutes and afterwards the solute 
was collected with a glass pipette and put into vials for the liquid chromatograph tandem 
mass spectrometry (LC-MS/MS) (Perkin-Elmer Biosystems, PE SCIEX API 3000, 
LC/MS/MS System, Triple quadrupole LC-MS/MS mass spectrometer). The vials were 
kept in a freezer at -20 degrees Celsius until analysis. Prior to the analysis all vials were 
centrifuged to make sure that there were no rests of glass wool in the analyte solute.  
 
C.1.1.3 Preparation of calibration standard series for the vapor samples  
Nicotine (Janssen Chimica) was weighed two times to make two separate calibration 
standard series. They were diluted in ethyl acetate, into concentrations from 12 ng/ml to 
13 µg/ml, to make two calibration standard series, each with seven points, from 0 ng/ml 
to 13 µg/ml. Then 1.9 ml of the different solutes with nicotine was put in a 5 ml glass test 
tube together with 0.1 ml of the IS described in E.1.1.2. The test tubes were shaken for 30 
minutes and the solute was transferred to a vial suited for the LC-MS/MS. The vials were 
stored until analyze in the freezer at -20 degrees Celsius. 
   
 
C.1.2 Nicotine Resin Complex 20% IRP   
C.1.2.1 Nicotine Resin Complex 20% IRP sampling procedure 
Sampling the NRC from the air in the Nicorette gum production was done with a Teflon 
filter (Gelman Sciences, Teflon TF 1000, diameter 37 mm, pore size 1 µm), placed in a 
filter cassette (Omega Specialty Instruments Co., filter cassettes 37 mm). The cassette 
was then attached to a rubber hose, which was attached to the pump. 
 
Samplings were done in different manners. One was personal air sampling, another was 
stationary area air sampling during a whole working day and the third was to measure the 
level of NRC when irritation11 is noticed.  The third mode of sampling was divided into 
three parts; “before – no”, “before and after – no and after” and “after – after” notice of 
irritation of the NRC, which was present in the ambient air. In the first two mentioned 
sampling modes around one liter of air was blown through the filter. In the latter three 
sampling modes, two liters of air were sucked through the filter. All sample equipment 
collected air in the breathing zone. (Figure A.5.2 – Map of the mixing room, Appendix 5) 
 
After sampling, the Teflon filters were collected from the filter cassettes and placed in a 5 
ml test tube; the tubes were marked and kept at -20 degrees Celsius until preparation. 
 
C.1.2.2 Extraction of nicotine from the Teflon filters and sample preparation 
Nicotine was extracted from the Teflon filter with ammonium hydroxide. The cat ion of 
nicotine in the resin was neutralized with 1 M ammonium hydroxide. The 1 M 
                                                 
11 Irritation – the irritation from the Nicotine Resin Complex 20% IRP gives cough, sour and irritate throat.   
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ammonium hydroxide was prepared from 25% ammonia solution (Merck Eurolab AB) 
and milli-Q water (at 18.0 MΩ) in proportions 7.5 to 100 [12]. Then 3 ml of 1 M 
ammonium hydroxide was added to the 5 ml test tube containing the sample Teflon filter. 
The test tubes were shaken vigorously for 20 minutes. Afterwards centrifugation was 
done for 12 minutes at 2500 rpm, and 2 ml of the clear solution were transferred to a 13 
ml test tube.  
 
The solved nicotine in the ammonium hydroxide was extracted liquid to liquid, to the 
ethyl acetate. After this 1.9 ml of ethyl acetate and 0.1 ml of the IS (10 µg/ml tri-
deuterium nicotine in ethyl acetate) was added to the sample solution of ammonia 
hydroxide. The test tubes with the mixture were shaken vigorously for 25 minutes. To 
make the two phases separate completely, the test tubes were centrifuged at 2000 rpm for 
10 minutes. The supernant was collected and put into a vial for analysis. Prior to the run 
in the LC-MS/MS apparatus, the vials were centrifuged. Until analyze, the samples were 
kept in the freezer at -20 degrees Celsius. 
 
C.1.2.3 Preparation of calibration standard series for the NRC samples 
For the calibration standard curves nicotine was weighed two times for two standard 
curves. The nicotine was diluted with 1 M ammonia hydroxide into concentrations of 0.3 
ng/ml to 20 µg/ml. The solutes of nicotine in ammonia hydroxide in each calibration 
standard series had 8 points. 2 ml of the calibration standard solute was put into a 13 ml 
test tube with 1.9 ml ethyl acetate and 0.1 ml IS tri-deuterium nicotine (the same IS used 
in the preparation of the samples in C.1.2.2). The test tubes were shaken vigorously for 
25 minutes. After that the test tubes were centrifuged at 2000 rpm for 10 minutes. The 
supernant was transferred to a vial for the analysis in the LC-MS/MS. The calibration 
standard series were kept together with the unknown samples in the freezer, at -20 
degrees Celsius, until time for analyze. 
 
 
C.1.3 Analysis of nicotine 
The separation procedure in the nicotine analysis is a short gradient separation (see step 
table A.4.1, Appendix 4). The mobile phase consists of a water based phase (10 mM 
ammonium acetate (Merck Eurolab AB), pH 9.5) – phase A, and an organic phase 
(methanol (Lab-Scan Analytical Sciences)) – phase B. First the nicotine is transported 
into the column (Agilent Technologies, Zorbax Extend-C18, 2.1 * 50 mm, 3.5 µm) with 
the mobile phase in the volume-to-volume ratio 99% of A to 1% of B. Because of the 
high concentration of the water phase in the mobile phase, the nicotine will have a strong 
affinity to the stationary phase. When the methanol enters the column in a higher 
concentration, 95% of B to 5% of A, the nicotine will disperse to the mobile phase much 
better. The nicotine will then elute in a high concentration. The ammonium acetate must 
be present in the mobile phase when nicotine is eluted. It is difficult to run nicotine in a 
chromatographic system, because of its tendency to interact with the stationary phase. 
The pH in the water phase is very important for the concentration of nicotine during the 
elution. Nicotine has a very strong power of sticking to the stationary phase. As an effect 
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of this strong reactivity the following negative results can be tailing tops12 or carry-over 
effects13.  
 
The analytes are ionized with electrospray ionization when entering the MS. The MS was 
adjusted to select the nicotine with the m/z 162.9 atomic mass units (amu), in the first 
quadrupole. The third quadrupole had the adjustments for the fragments of the m/z 130.1 
amu and also the m/z 84.3 amu. For the calculation of the concentrations of nicotine the 
m/z 162.9 and 130.1 were used. For the IS of tri-deuterium nicotine, the first quadrupole 
was adjusted to the m/z 166.0 amu and after the fragmentation the third quadrupole was 
adjusted to the m/z 87.3 amu.  
 
C.2 Cotinine 
C.2.1 Specimens of urine 
C.2.1.1 Urine sampling procedure 
To analyze the exposure to nicotine, urinary cotinine was used as its biomarker. The test 
persons gave a zero-sample, a specimen of urine, the morning of the same day the 
exposure to nicotine was expected. Then they gave a specimen of urine the morning after 
participating in the sampling of nicotine in the air inside the production rooms. 
 
The specimens of urine were collected on the same day as they were given and kept 
frozen at -20 degrees Celsius until preparation. They thawed in 4 degrees Celsius over 
night before preparation. 
 
C.2.1.2 Isolation of cotinine from the specimen of urine and preparation of calibration 
standard series 
A specimen of urine was collected from a person who had no known exposure to nicotine 
for at least one and a half weeks. This sample was used for the calibration standard 
preparation. The importance of the non-exposed person is that the sample does not 
contain any cotinine. 
 
Cotinine (Sigma Chemical Co.) was weighed two times to make two calibration standard 
series. Then the two sample series were diluted with methanol into concentrations from 
0.3 ng/ml to 4 µg/ml.  
 
50 µl and 100 µl of the calibration standards were applied together with 100 µl of the 
internal standard tri-deuterium cotinine (Sigma Chemical Co.) of 200 ng/ml to 1 ml of the 
urine in a 13 ml glass test tube. The concentration of cotinine in the solutions provide two 
                                                 
12 Tailing top – the highest concentration of the analyte comes to the detector first. Because of the analyte’s 
high affinity to the column’s stationary phase some of the analyte elutes with longer retention time. 
13 Carry-over effect – some of the analyte can stick to the injection needle, column or other parts of the 
analytical instrument, that may result in the wrong analyze-result in the following analyze run. The result in 
the former run may be too small and the result of the latter run may be too big. 
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standard stocks, each with nine points, from 0 (blank14) to just above 200 ng per ml of 
urine, every calibration standard has 20 ng of the IS tri-deuterium cotinine per ml urine as 
well. The method used to isolate the cotinine from the specimen of urine has the same 
procedure as the method for the preparation of the calibration standard. 1 ml of the urine 
from the specimens of urine was mixed together with 100 µl of the IS tri-deuterium 
cotinine in a 13 ml glass test tube.   
 
To each unknown sample of urine and each stock of calibration standard, 7 ml of ethyl 
acetate and 1 ml of 5 M potassium hydroxide (Merck Eurolab AB) were added. The 
samples and the calibration standard stock solutions were then shaken vigorously for 15 
minutes and the test tubes were centrifuged at 2000 rpm for another 15 minutes. The 
organic supernatant was collected and transferred to another 13 ml test tube of glass. The 
test tubes were then placed in the evaporator for around 45 minutes at 45°C. After 
evaporation, 100 µl of methanol was used to resolve the cotinine and the internal standard 
in the test tubes. The solute was transferred into a micro-vial, which was placed inside a 
vial, positioned in the liquid-chromatographic instrument for analysis. [13] 
 
Because of the large amount of samples, they were prepared on different occasions, for 
example when a new set of samples was prepared and when fresh calibration standards 
were prepared.  
 
 
C.2.2 Analysis of cotinine  
The analyzing process of cotinine in the LC-MS/MS is done with a gradient (see step 
table A.4.3, Appendix 4). First the mobile phases, 95% of water based phase (10 mM 
ammonium acetate, pH not adjusted – phase A) and 5% of organic phase (methanol – 
phase B) transport the cotinine and other substances to the column (Agilent 
Technologies, Zorbax C18, 4.5 * 50 mm, 5 µm). The gradient changes the concentrations 
to 5% of the water phase and 95% of the organic phase for four minutes. The cotinine 
will then elute sharply, in a very high concentration. After four minutes the 
concentrations return to their initial values, for six seconds, and the initial concentrations 
last for the rest of the analytical program. [13] 
 
In the entrance of the MS the analytes are ionized with electrospray ionization.  In the 
analysis of cotinine, the first quadrupole of the MS was adjusted to the m/z 177.0 amu for 
cotinine and m/z 179.0 amu for the IS of tri-deuterium cotinine. The third quadrupole was 
adjusted to m/z 80.1 amu and m/z 98.2 amu to select the fragments from cotinine and the 
m/z 80.3 amu for the IS.  
 
C.2.3 Density of urine and urinary concentrtion of creatinine 
The density of urine is measured with a refractometer15 (Hand Refractometer, Ladassco 
ATAGO). The measurement of the concentration of creatinine has been performed by the 
Laboratory of Clinical Chemistry and Pharmacology at the University Hospital in Lund. 
                                                 
14 Blank – a blank sample does not contain any of the substances analysed, but the internal standard is 
usually present. 
15 Refractometer – an instrument that measure the angle of refraction of a liquid. 
 16
 C.3 Exposure calculation 
The concentration of nicotine has been calculated using Calculation 1 or 2 (Appendix 6), 
depending on, in which production room the measurements have been done. The 
individual exposure has been estimated as the concentration of nicotine in the air for the 
employee multiplied by the rate of breathing, multiplied by the time working in the 
production room (Calculation 3, Appendix 6).  
 
C.4 Quantification 
The quantifications of the different analytes were done by using standard calibration 
curves from the standard series of analytes prepared from nicotine and cotinine. In every 
standard series sample a specific and identical amount of the internal standard, either tri-
deuterium nicotine or tri-deuterium cotinine, was added. The points of the standard series 
samples weighed concentrations were plotted to the results from the LC-MS/MS. The 
results from the LC-MS/MS were the areas from the analyte (nicotine or cotinine) 
divided to the area of the internal standard. A standard calibration curve was fitted to the 
points.  
 
To receive the concentration of the unknown samples, a calculation based on the function 
of the standard calibration curves was used. The analyte’s area results divided by the 
internal standard results from the unknown samples were fitted into the function and the 
concentrations were calculated.    
 
The limit of detection was estimated according to the concentrations of the calibration 
standard series for the different analytical series. 
 
The analytical series of nicotine were prepared differently and consequently the 
concentration of tri-deuterium nicotine varied in the different analytical runs and the 
calibration curves got different gradients. 
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D Results 
D.1 Nicotine 
D.1.1 XAD-2 tubes 
The limit of detection, in the LC-MS/MS system, for the concentration of nicotine vapor, 
from the extraction of the XAD-2 tubes, is estimated to 10 ng/ml.  
 
The peak in figure D.1 shows the chromatogram of nicotine absorbed in the first layer of 
sorbent – A – in one of the XAD-2 tubes. Figure D.2 shows the chromatogram of the 
internal standard tri-deuterium nicotine, applied to the sample shown in figure D.1. 
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Figure D.1: Nicotine in the air in the Nicorette patch production, XAD-2 layer A.  
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Figure D.2: Internal standard tri-deuterium nicotine in the sample of figure D.1. 
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The second sorbent layers – B – were run separately from the first layers – A. Figure D.3 
shows the chromatogram of nicotine in the layer B and figure D.4, the chromatogram of 
the internal standard tri-deuterium nicotine. 
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Figure D.3: Nicotine in the air in the Nicorette patch production, XAD-2 layer B. 
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Figure D.4: Internal standard tri-deuterium nicotine in the sample of figure D.3. 
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D.1.2 Teflon TF-1000 filters 
In the NRC analysis of nicotine extracted of the Teflon filters and the NRC, the limit of 
detection for the concentration of nicotine is estimated to 10 ng/ml. 
D.1.2.1 NRC in air when no irritation is noticed 
The analysis of the Teflon filters from the sampling in the Nicorette gum production gave 
the results shown in the figures below. Figure D.5 shows the chromatogram of nicotine in 
the air when no irritation occurs, below the irritation level. Figure D.6 shows the 
chromatogram of the internal standard tri-deuterium nicotine applied to the sample that is 
found in figure D.5. 
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Figure D.5: Nicotine in the air when no irritation is noticed in the Nicorette gum production, Teflon filter. 
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Figure D.6: Internal standard tri-deuterium nicotine in the sample of figure D.5. 
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D.1.2.2 NRC in air above irritation level 
One result of the nicotine in the air, in the production room, when irritation occurs is 
shown in the chromatogram in figure D.7. Figure D.8 shows the chromatogram of the 
internal standard tri-deuterium nicotine that is applied to the sample of figure D.7. 
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Figure D.7: Nicotine in the air above irritation level in the Nicorette gum production, Teflon filter. 
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Figure D.8: Internal standard tri-deuterium nicotine in the sample of figure D.7. 
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D.2 Cotinine  
For the biological samples of the specimens of urine, the estimated limit of detection for 
the concentration of cotinine is 1 ng/ml. 
 
One peak of cotinine in the specimen of urine is shown in the chromatogram in figure 
D.9. The peak of the internal standard tri-deuterium cotinine from figure D.9 is shown in 
the chromatogram in figure D.10. 
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Figure D.9: Urinary cotinine from the exposure to nicotine in the Nicorette production. 
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Figure D.10: Internal standard tri-deuterium nicotine in the sample of figure D.9. 
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D.3 Nicorette patch production 
D.3.1 Concentration of nicotine in the air in the coating room 
The results from the area sampling in the coating room are presented in figure D.11. The 
concentration of nicotine is low. Figure D.11 shows how much nicotine is present in the 
ambient air during a full working day, approximately eight hours. Sampling is done in the 
breathing zone in no direct connection with the Mark Andy (figure A.5.1 - Map of the 
coating room, Appendix 5). Days 9 and 17 have two result bars, as production was 
running in two coating rooms those days.  
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Figure D.11: Concentration of nicotine in the ambient air from stationary sampling, in the Nicorette patch 
production room. Every result bar shows an overall concentration of nicotine in the coating room for a 
working day. The pumps were positioned at different positions, 1, 2 and 3 in the room (figure A.5.1 
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Table D.1: Concentration of nicotine in the ambient air from stationary sampling, in the Nicorette patch 
production room. 
 
 Median Mean Range 
Nicotine µg/m3 1.8 2.0 0.1 – 7.1 
 
Days 11, 12 and 19 the pump with the absorbent XAD-2 tubes was further away from the 
Mark Andy than the other days. They are positioned close to the doors of the coating 
room (figure A.5.1, Appendix 5). The second bar, day 9*, and the first bar, day 17*, the 
XAD-2 tubes were positioned in coating room 2. The distance to the bench, where the 
Nicorette patches are stacked together, is shorter than in the coating rooms 1 or 3, where 
the other samples are taken. The first result bar day 17 and the result bar day 18 are 
measured both by the doors and close to the bench. Days 1 to 9 (first result bar), day 10 
and days 15 to 16 the measurement was made at the same position by the wall where the 
garbage cans are (position 1, figure A.5.1, Appendix 5). The average concentration of 
nicotine vapor is only 2.0 µg/m3 (see table D.1), in the ambient air in the coating room, 
which lies very much below the TLV16 (500 µg/m3). There is no connection between the 
                                                 
16 TLV = Threshold Limit Value 
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different concentrations of nicotine in the air in the coating room and the different 
Nicorette patch types: 5, 10 and 15 mg. 
 
D.3.2 Concentration of nicotine in the air by the reception position 
The concentration of nicotine in the air is much higher for the employees at the reception 
position (figure A.5.1, Appendix 5) than it is in the ambient air in the coating room. 
Figure D.12 shows the results from the nicotine analysis of the XAD-2 sorbent sample 
cartridges sampled at the reception position. During day 9 and day 17 measuring was 
Figure D.12: Concentration of nicotine in the air by the r
done at the reception position in two coating rooms.  
eception position in the Nicorette patch 
ays 3, 11 and 12 there were more than one 
Figure D.13: Concentration of nicotine by  
 
 
                                                
production room. Day 12 two XAD-2 tubes were used at the same position. Production was going on in two 
rooms during days 9 and 17. 
  
 
D
XAD-2 tube measuring the concentration of 
nicotine by the reception position. The result bar 
of days 3, 11 and 12 in figure D.13 shows the 
concentration of nicotine while the Mark Andy 
runs one hour without any short stops17. It can 
be seen that more nicotine is present when the 
Mark Andy runs continuously. The result bar of 
day 11 (figure D.13) has the highest 
concentration result of all the measurements, 
74.3 µg/m3. Because on that occasion the Mark 
Andy ran continuously.   
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the reception position by the Mark Andy
during continuous production. 
 
17 Short stop – the Mark Andy machinery is only stopped during the changing of the different articles of 
consumption when manufacturing. 
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Table D.2: Concentration of nicotine in the air by the reception position in the Nicorette patch production 
room. 
 
 Median Mean Range 
Nicotine µg/m3 27 26 11 – 66 
5 mg Nicorette patch µg/m3 24 25 11 – 39 
10 mg Nicorette patch µg/m3 26 26 23 – 30 
15 mg Nicorette patch µg/m3 27 32 18 – 66 
Nicotine (continuous 
production) µg/m3 50 53 35 – 74 
 
Table D.2 shows no significant patterns in the concentration of nicotine at this sampling 
position when different Nicorette patch types (5, 10 or 15 mg) are manufactured. Row 
number 5 in table D.2 shows the concentration of nicotine when the Mark Andy runs 
continuously. 
 
 
D.3.3 Concentration of nicotine in the air by the waste roll at the Mark Andy 
The sampling tools were attached to the Mark Andy (figure A.5.1, Appendix 5) to see 
how much nicotine the waste roll18 emits. The results are found in table D.3 and show the 
concentration of nicotine just near the waste roll. The results come from two different 
sampling days. After the waste roll is full, it is placed inside a plastic waste bag and 
thrown into a garbage can, placed inside the coating room. The handling of the full waste 
roll has not been measured separately. Table D.3 shows the median, the mean and the 
range of the concentrations of nicotine that is sampled. 
 
Table D.3: Concentration of nicotine in the air by the Nicorette patch waste roll. 
 
 Median Mean Range 
Nicotine µg/m3 4.8 4.8 4.8 – 4.8 
 
 
D.3.4 Individual exposure in the coating room 
In figure D.14 the individual exposure to nicotine is presented for one working day. 
When performing different working operations inside the coating room; the personal 
sampling equipment has been used during this time (figure A.5.1, Appendix 5). Table D.4 
shows the median, the mean and the range from concentration of nicotine, the time spent 
in the coating room for all the employees participating in the study. Table D.4 also shows 
the median, the mean and the range of the total nicotine exposure and of the cotinine 
content in the specimens of urine from employees (marked with *) with a low zero value 
of cotinine on the first day of sampling. 
 
                                                 
18 Waste roll – it is the waste after the Nicorette patches are punched, which is rolled up. 
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Figure D.14: Individual samples of the exposure to nicotine from the air by the Nicorette patch production. 
Every result bar shows the result of each of the concentration from the employee’s XAD-2 tube that 
particular day of sampling, multiplied by the time spent inside the coating room. 
 
Table D.4: Individual samples of the concentration of nicotine from the air by the Nicorette patch 
production and the time the employees spent inside the coating room. The nicotine exposure and the values 
of cotinine, which are presented in the table (* in figure D.14 and table D.4) comes from the employees 
that had low zero values of cotinine in the specimens of urine on the first day of sampling.  
 
 
 Median Mean Range 
Nicotine concentration 
in the air µg/m3 17 17 7.0 – 25 
Time min 270 260 150 - 400 
Nicotine exposure* 
µg*h/m3 80 68 17 – 110 
Cotinine* µmol 
/Creatinine mol 3.3 5.1 0.8 – 12 
Cotinine* nmol/l 61 66 12 – 130 
Cotinine* ng/ml 10 10 6 – 18 
The results of the analysis of cotinine in the specimens of urine (samples with lower 
concentration of cotinine than 4 ng/ml), from the first day of exposure at the production, 
have been compared to the amount of nicotine in the XAD-2 tubes carried by the 
employees the first day, while they were working inside the coating room. The nicotine 
exposure values (µg*h/m3) in table D.4 and figures D.14, D.15, D.16 and D.17 come 
from calculation 3, Appendix 6, which uses the nicotine exposure from the air found in 
the XAD-2 tube multiplied by the time in the production. Figure D.15 shows each 
person’s exposure to nicotine in the air and the following day’s contents of cotinine 
(µmol/l) in the morning urine divided by the contents of the creatinine (mol/l), see 
calculation 4b, Appendix 6. The nicotine exposure from the air and the urinary cotinine 
adjusted to the density of the urine, see calculation 4b, Appendix 6, are presented in figure 
D.16. Figure D.17 shows the concentration of cotinine from the specimens of urine, with 
no adjustments for any dilution or rate of secretion, and the exposure to nicotine in the air 
that working day.  
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Figure D.15: Exposure to nicotine in the air, in 
the Nicorette patch production, and the urinary 
cotinine adjusted to the urinary creatinine, from 
the employees with a low zero value of cotinine.  
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Figure D.16: Exposure to nicotine in the air, in 
the Nicorette patch production, and the urinary 
cotinine adjusted to the density of the urine, from 
the employees with a low zero value of cotinine.  
 
 
 
Figure D.17: Exposure to nicotine in the air, in 
the Nicorette patch production, and the 
concentration of cotinine in the specimens of 
urine, with no adjustments, from the employees 
with a low zero value of cotinine. 
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D.4 Nicorette gum production 
D.4.1 Concentration of nicotine in the air in the mixing room 
In figure D.18 the results of the concentration of nicotine in the air of the production 
room are shown. The results come from stationary area sampling (figure A.5.2 - Map of 
the mixing room, Appendix 5); they show the concentration of nicotine in the mixing 
room for one working day, approximately eight hours. Result bar day 2 shows a higher 
concentration of nicotine as that day the glove box was not closed when the NRC was 
filled into the container below, and on one occasion day 2 the air extraction through the 
perforated bench was not running either. Table D.5 shows the median, the mean and the 
range of the concentrations of nicotine found in the samples from the mixing room for the 
Nicorette gum. 
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Figure D.18: Concentration of 
nicotine from the NRC in the air 
in the Nicorette gum production 
room. The results come from 
stationary sampling and show 
the average concentration of 
nicotine per working day. 
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Table D.5: The average concentration of nicotine (NRC) in the air per day from stationary sampling in the 
Nicorette gum production room. 
 
 Median Mean Range 
Nicotine (NRC) µg/m3 3.1 (15) 4.2 (21) 0.1 – 15 (0.5 – 75) 
 
D.4.2 Individual exposure in the mixing room 
Figure D.19 shows the individual exposure to the nicotine in the NRC found in the 
personal air samples from the Nicorette gum production, multiplied by the time spent 
inside the mixing room, (figure A.5.2, Appendix 5). Table D.6 shows the median, the 
mean and the range of the concentration of nicotine and NRC, the time the employees 
were in the mixing room, the total nicotine exposure from the NRC in the air and the 
values of cotinine, which are found in the specimens of urine. 
 
Figure D.19: Individual samples of 
the exposure to nicotine from the 
NRC in the air by the Nicorette 
gum production. Every result bar 
shows the result of each sample 
that particular day, multiplied by 
the time spent inside the mixing 
room. 0
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Table D.6: Individual samples of the concentration of nicotine from the NRC in the air by the Nicorette 
gum production, the time the employees spent inside the mixing room, the total nicotine (NRC) exposure 
and the values of cotinine from the specimens of urine. 
 
 Median Mean Range 
Nicotine (NRC) µg/m3 24 (120) 35 (175) 6.0 – 82 (30 – 410) 
Time min 210 180 29 – 300 
Nicotine (NRC) 
µg*h/m3  62 (310) 90 (450) 20 – 310 (100 - 1550) 
Cotinine 
µmol/Creatinine mol 
2.5 3.4 1.1 – 7.3 
Cotinine nmol/l 42 61 8.7 – 130 
Cotinine ng/ml 10 10 6 – 18 
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The urinary cotinine from the specimens of urine (samples with lower concentration of 
cotinine than 4 ng/ml), from the first day of exposure, to the nicotine measured in the 
airborne NRC that the employees were exposed to the first working day, is shown in 
figures D.20, D.21 and D.22. The exposure is estimated with calculation 3, Appendix 6.  
Figure D.20 presents the cotinine, adjusted to creatinine and the nicotine exposure that 
day, see calculation 4a, Appendix 6. Figure D.21 presents the cotinine, adjusted to the 
density of the urine and the nicotine exposure, see calculation 4b, Appendix 6. Figure 
D.22 shows the concentration of cotinine from the specimens of urine with no 
adjustments for any dilution or rate of secretion and the exposure to nicotine from the 
NRC in the air that working day.  
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Figure D.20: Exposure to nicotine from the NRC 
in the air, in the Nicorette gum production, and 
the urinary cotinine adjusted to urinary 
creatinine.  
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Figure D.21: Exposure to nicotine from the NRC 
in the air, in the Nicorette gum production, and 
the urinary cotinine adjusted to the density of the 
urine. 
 
 
Figure D.22: Exposure to nicotine from the NRC 
in the air, in the Nicorette gum production, and 
the concentration of cotinine in the specimens of 
urine, with no adjustments. 
D.4.3 Effects of the Nicotine Resin Complex 20% IRP 
The samplings presented in D.4.3, for measuring the level of irritation of the NRC, have 
been done in the mixing room during very short sampling times (see my position in figure 
 30
A.5.2, Appendix 5). During days 1 to 5, filter 1,X to 5,X, 4 mg Nicorette gums were 
produced and days 8 to 12, filter 8,X to 12,X, 2 mg Nicorette gums. The results presented 
in figures D.23 and D.24, and tables D.7 and D.8 all come from samplings for between 
1.5 and 5 minutes. The concentrations of nicotine (µg/m3) shown in the figure below, 
figure D.23, caused no irritation. Table D.7, shows the median, the mean and the range of 
concentrations for nicotine from the NRC, when no irritation is noticed.  
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Figure D.23: Concentration of nicotine 
from the NRC in the air, in the Nicorette 
gum production room, when no irritation is 
noticed. 
 
 
 
 
 
 
 
 
Table D.7: Concentration of nicotine (NRC) in the air, in the Nicorette gum production room, when no 
irritation is noticed. 
 
 Median Mean Range 
Nicotine (NRC) µg/m3 2.8 (14) 4.3 (22) 1.6 – 18 (8.0 - 90) 
 
Figure D.24, below, shows the concentration of nicotine (µg/m3) from the NRC in the air 
when the irritation is noticed. The figure shows no specific difference between minor or 
severe irritation. Table D.8 gives the median, mean and range values for the 
concentrations of NRC and nicotine after irritation is noticed. 
0
20
40
60
80
100
120
140
N
ic
ot
in
e 
( µg
/m
3 )
4,
2
4,
3
4,
8
4,
9
5,
4
5,
7
5,
13
5,
14
8,
21
8,
24
8,
25
8,
26 9,
6
9,
9
9,
10
9,
11
9,
12
9,
13
9,
16
11
,1
0
12
,1
12
,2
12
,4
12
,5
12
,6
12
,8
12
,1
0
12
,1
1
Day, filter
Figure D.24: Concentration of nicotine from the NRC in the air, in the Nicorette gum production room, 
when irritation is noticed. 
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Table D.8: Concentration of nicotine from the NRC in the air when irritation is noticed, in the Nicorette 
gum production room. 
 
 Median Mean Range 
Nicotine (NRC) µg/m3 23 (115) 31 (155) 2.5 – 120 (13 – 600) 
 
It is obvious that on some occasions no irritation was indicated, but on other occasions 
irritation occurred at lower and at the same levels of nicotine in the air.  
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E Discussion  
 
The work at Pfizer’s Nicorette production involves constant exposure to nicotine. The 
concentration of nicotine in the manufacturing rooms is many times and sometimes more 
than several hundred times lower than the TLV. The amount of nicotine in the air varies 
rather much between different areas in the rooms. Consequently the exposure varies 
depending on the different tasks that are performed.  
 
E.1 Concentration of nicotine in the air in the Nicorette patch and Nicorette 
the gum production rooms 
In the Nicorette patch production room, the coating room, the mean concentration of 
nicotine in the ambient air is 2 µg/m3 (table D.1). In figure D.11 clear differences can be 
seen between the different sampling places where the XAD-2 tubes with pumps were 
stationed. The closer to the bench, where the Nicorette patches were kept until stored, the 
sampling was done, the higher was the concentration of nicotine. The concentration in the 
coating room is on average more than 10 times lower than the average concentration of 
nicotine at the reception position of the Nicorette patches, 26 µg/m3, (table D.2). In table 
D.3, the concentration of nicotine by the patch waste roll is presented. It was measured to 
less than 5 µg/m3, which indicates that well positioned point air extractors reduce the 
concentration of nicotine in the air close to the Mark Andy.  
 
In the Nicorette gum production room, the mixing room, the concentration of nicotine in 
the air from the NRC is found to be 4.2 µg/m3, which is equal to 21 µg/m3 of NRC on an 
average working day, table D.5 and figure D.18. That is twice as high a concentration of 
nicotine as the concentration in the Nicorette patch production. In this production, the 
source of NRC in the air is limited to the tasks when the NRC is filled into the containers. 
Then there is a high, temporary rise of  NRC in the air. 
 
The concentration of nicotine in the Nicorette patch and the Nicorette gum production 
rooms are below the TLV stated to 500 µg/m3.  
 
E.2 Exposure to nicotine from the air in the Nicorette patch and the Nicorette 
gum production 
The concentrations of nicotine in the individuals at the Nicorette patch production (figure 
D.14) were several times higher than the concentration in the ambient air. The employees 
are exposed to an average concentration of 15 µg/m3 nicotine from the air, for a working 
day. They work inside the coating room for 4 hours and 25 minutes on average. During 
this time they are at the reception position, where most of the exposure comes from, for 2 
to 3 hours per day. They take the Nicorette patches from the reception to the bench where 
they are for at least another hour and throw away the waste roll or change the nicotine 
bottle for 15 to 30 minutes, but some days they never perform those tasks. The individual 
air sample of nicotine may have a higher concentration when the employee has changed 
the nicotine bottle, though a mask with a fresh airflow is used. The pump with the XAD-2 
is placed offside the mask and nicotine vapor may therefore reach the XAD-2 cartridge 
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but not the employee. The individual difference of the nicotine exposure from the air is 
mostly due to the difference in time, spent at the reception position. The exposure 
(calculation described in chapter C.3) in the production of Nicorette patch is on average 
69 µg*h/m3 from the nicotine in the air (table D.4).  
 
The employees, in the Nicorette gum production, do not stay inside the mixing room for 
an entire shift, on average they work there for 2 hours and 55 minutes (table D.6). There 
they are exposed to a greater concentration of nicotine, from the NRC, than the average 
concentration of nicotine vapor in the coating room, see tables D.4 and D.6. That is 
because they handle the NRC, which dusts. In table D.6 the individual nicotine exposure 
from the NRC is found to be on average 90 µg*h/m3, which equals 450 µg*h/m3 of NRC, 
from the calculation described in chapter C.3.  
 
Depending on the two different Nicorette gum types, 2 and 4 mg, it can be seen that a 
greater concentration of NRC is found in the air when the 4 mg gums are produced. 
When the double quantity of NRC is filled into the container more NRC-dust fills the 
room, see figure D.23, D.24 and D.25.  
 
E.3 Exposure to nicotine correlated to the concentration of cotinine in the 
specimens of urine 
The cotinine is present at a very low concentration in mostly all humans. The exposure 
from environmental tobacco smoke is one source of the urinary concentration of cotinine, 
another source can be food that contains nicotine. Even the specimen of urine, which was 
used to the standard series, had a small concentration of cotinine. To correct the 
concentrations of cotinine in the calibration standard series, 1.1 ng/ml cotinine was added 
to all the concentrations which were used to 
the calibration standard series. Urinary 
cotinine in the employees’ samples was 
fitted to the different standard curves. One 
standard curve was used for results with 
concentrations below 10 ng/ml (57 nmol/l) 
and another for results with concentrations 
above. For the curve with low concentrations 
of urinary cotinine, the points of the highest 
concentrations of the standard series were 
not used.  
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The relation between the concentrations of 
cotinine adjusted to the two parameters, 
urine density and urinary creatinine, is 
shown in figure E.1.  
 
Figure E.1: Concentration of cotinine adjusted to  
urine density compared to cotinine adjusted to the  
concentration of creatinine. 
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The concentration of cotinine adjusted either to urinary density or concentration of 
creatinine has clear individual differences. The creatinine adjustment is very individual as 
well as the adjustment to density. [10] The individual metabolic differences are also very 
important. Some people metabolize more cotinine than others and consequently the 
results between different people can vary a lot. [2, 3]  
 
The values of exposure to nicotine from the air and the corresponding concentrations of 
cotinine from another study [13] were used to determine if there was another source of 
exposure than from the air. In figure E.Y, the exposure to nicotine and the concentration 
of cotinine from the employees in the Nicorette patch production is compared to the 
subjects’ (from [13]) exposure to nicotine, presumably from the air, and their 
concentration of cotinine. The same kind of comparison between the Nicorette gum 
employees’ exposure to nicotine from the NRC in the air and the concentration of 
cotinine, and the other study’s [13] nicotine and cotinine values has been done. In the 
figures E.2 and E.3, the zero concentrations of cotinine in the urine were low, below 4 
ng/ml. 
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Figure E.1: Linear regression of the exposure to 
nicotine in the air at the Nicorette patch 
production and the concentration of cotinine in the 
specimens of urine. The dotted regression line 
corresponds to urinary cotinine and a presumable 
exposure to nicotine from the air [13]. 
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Figure E.2: Linear regression of the exposure to 
 
he exposure to nicotine in 2004 at the Nicorette patch and the Nicorette gum 
nicotine from the NRC in the air at the Nicorette 
gum production and the concentration of cotinine 
in the specimens of urine. The dotted regression 
line corresponds to urinary cotinine and a 
presumable exposure to nicotine from the air [13]. 
 
T
production, compared to the exposure in the year 2002 at the same production sites is 
shown in the tables below. Tables E.1.1 and E.1.2 present the Nicorette patch production 
and tables E.2.1 and E.2.2 present the exposure at the Nicorette gum production.  
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Table E.1.1: Median, mean and the range of the exposure to nicotine in the air in the Nicorette patch 
production, urinary concentration of cotinine, cotinine adjusted to creatinine and cotinine adjusted to 
density. 
 
2004 Median Mean Range 
Nicotine µg*h/m3 80 68 17 – 110 
Cotinine ng/ml 10 10 6 – 18 
Cotinine µmol/Creatinine mol 3 5 1 – 12 
Cotinine nmol/l 61 66 12 – 130 
 
 
Table E.1.2: A mean value of a calculated exposure to nicotine in the Nicorette patch production in 2002, 
median, mean and the range of the urinary concentration of cotinine and cotinine adjusted to creatinine. 
 
2002 [14] Median Mean Range 
Calculated value of exposure  
to nicotine µg*h/m3 - 100 - 
Cotinine ng/ml 6 11 1 – 49 
Cotinine µmol/Creatinine mol 4 6 2 – 22 
 
In the Nicorette patch production, for three persons, there must be some other source of 
exposure than the exposure from the air, according to figure E.1. In tables E.1.1 and E.1.2 
it can be seen that the levels of cotinine in the urine are approximately the same, while 
the calculated value of exposure to nicotine in 2002 is around 50 % higher than the 
exposure to nicotine that has been measured in the air samples. The urinary cotinine 
shows that the exposure to nicotine overall in the Nicorette patch production has not been 
reduced since the study of the exposure to nicotine in 2002. 
 
Individually, it is clear that some employees (1, 4 and 5 in table A.1.1, Appendix 1) must 
have been exposed to more nicotine than the nicotine vapor present in the air. It is their 
points in figure E.1 that increase the gradient of the regression line for the concentration 
of cotinine to the exposure of the nicotine plot. The amount of cotinine in the specimens 
of urine from the employees at the Nicorette patch production does not show a direct 
relationship between the nicotine in the air and the concentration of cotinine (ng/ml). The 
same can be said about figures D.15 and D.16. On average the urinary cotinine increases 
without any direct increase of the concentration of nicotine in the air. That extra urinary 
cotinine must come from another source of exposure. That source is probably the dermal 
route. Nicotine enters the skin very easily. Sometimes the employees use one pair of 
rubber gloves on top of cotton textile gloves (employees 1, 3 and 5, table A.1.1, Appendix 
1), which do not protect the hands from exposure as much and for as long as two layers 
of the rubber gloves do [11]. The employees may have used the same pair of rubber 
gloves for too long as well, and thus the nicotine might have penetrated the rubber and 
reached the skin.   
 
In the Nicorette gum production the employees use their rubber gloves for just the 
moments they handle the NRC, filling the containers. They also normally wear a 
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disposable mask for protecting the respiratory tract from exposure to NRC. Nicotine is 
only released from NRC in contact with saliva, water or when heated [15]. 
 
The exposure to nicotine, from the NRC, in the Nicorette gum production has been 
reduced since 2002 according to the cotinine content found in the employees’ urine, see 
tables E.2.1 and E.2.2.  
 
Table E.2.1: Median, mean and the range of the exposure to nicotine, from the NRC, in the air in the 
Nicorette gum production, urinary concentration of cotinine, cotinine adjusted to creatinine and cotinine 
adjusted to density. 
 
2004 Median Mean Range 
Nicotine (NRC) µg*h/m3 62 (310) 90 (450) 20 – 310 (100 – 1550) 
Cotinine ng/ml 9 11 2 – 23 
Cotinine µmol/Creatinine mol 3 3 1 – 7 
Cotinine nmol/l 42 61 9 – 130 
 
 
Table E.2.2: Range values of a calculated exposure to nicotine from the NRC in the Nicorette gum 
production in 2002, median, mean and the range of the urinary concentration of cotinine and cotinine 
adjusted to creatinine. 
 
2002 [14] Median Mean Range 
Calculated value of exposure  
to nicotine (NRC) µg*h/m3 - - 400 – 700 (2000 – 3500) 
Cotinine ng/ml 37 37 11 – 62 
Cotinine µmol/Creatinine mol 17 17 11 – 22 
 
The employee correlated to result bar number 1, 2 and 3 in figure D.19 (employee with 
the numbers 1.1, 1.2 and 1.3 in table A.1.2, Appendix 1) did not use the glove box 
cupboard in the closed position when filling the container with NRC. Day 2 the 
extraction through the bench inside the glove box was not running, and the room was 
immediately filled with NRC-dust. The employee correlated to result bar 7, figure D.19 
(employee number 5.1 in table A.1.2, Appendix 1), was using a half-mask when 
performing the tasks of handling the NRC and the door of the glove box was open. 
During the other time when he was working in the mixing room no mask was used at all. 
The result bar numbers 6 and 9 in figure D.19 (employees numbers 4.1 and 7.1 in table 
A.1.2, Appendix 1) shows the workers who, this particular day filled the NRC, into the 
container below the glove box on one occasion only. Number 6 (4.1) was in the mixing 
room for just half an hour on the day of sampling. The employee correlated to result bar 
number 4, figure D.19, (number 2.1 in table A.1.2, Appendix 1) worked during the 
longest time in the mixing room and performed four premixes according to all the 
instructions (it is possible during a working day, to perform five premixes when 
everything functions well). That result shows that if the directions are followed the 
exposure is not very high. The exposure is related to how much work is carried out on a 
particular day; the more work at the glove box cupboard – filling the container for NRC – 
the more exposure. The cleaning of the premix containers is often done with high-
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pressure air, which makes the NRC at the container and wherever else it has settled, whirl 
up and the mixing room becomes dust-laden once more. 
 
In figure E.3, it is clear that the concentration of cotinine is lower than the expected 
concentration of cotinine due to the nicotine exposure, for three persons, the one that used 
a half-mask19 and two that used the protective mask. The mask that protects the 
respiratory tract used by the employees when working inside the mixing room, in the 
Nicorette gum production, did according to the plot in figure E.3, keep the exposure to 
the NRC and also the nicotine low. For the other two persons in figure E.3, the exposure 
was not reduced. The risk of errors, see below and chapter A.3.2, is in fact too big to say 
for sure that the mask protects the respiratory region from exposure to the NRC. 
 
The metabolic differences cannot be neglected either, as mentioned earlier (chapter 
A.3.2). When the urinary concentrations of cotinine are as low as they are in this 
research, the exposure from other sources, like the environmental tobacco smoke, may 
have a big influence on the analytical results. Exposure from other sources may give a 
concentration of cotinine in the specimens of urine that does not correspond to the air 
samples of the concentrations of nicotine when they are as low as they are in the coating 
and the mixing rooms. 
 
All the results from the specimens of urine cannot be used as some subjects have been 
exposed to other sources of nicotine. One employee had a zero-concentration of cotinine 
several hundred times higher than the non-exposed employees (see employee number 9, 
table A.1.1). These amounts of cotinine have a nicotine source corresponding to several 
cigarettes. A couple of other employees (see employees numbers 7 and 8, table A.1.1) 
must also have been exposed to much environmental tobacco smoke, or used nicotine 
days prior to the sampling of urine, so their urinary cotinine was not used either.   
  
E.4 Effects from the Nicotine Resin Complex 20% IRP in the air 
The symptoms of irritation that have been studied are my own. Consequently, the level of 
sensation is subjective and thus the results. Notes of how much irritation occurred and if 
the employees felt irritation as well, were done while the air samples were collected. The 
irritation from the NRC that I felt appeared especially in the nasal cavity, the pharynx and 
the larynx regions and consisted of coughs and a sour throat. I could notice that I got 
accustomed to and insensible to the irritating NRC dust when being in the mixing room 
during a working day. The longer the time I spent inside the mixing room, when the tasks 
of filling the containers with the NRC were performed, the less acute were the irritation 
and the severe coughs. But even when not coughing I was always feeling the sour throat. 
It was obvious that whenever the employees coughed I coughed as well, but often I 
coughed and the employees did not. For the day-to-day level of irritation I could feel less 
severe irritation but no indications of any trend of absence of irritation from the NRC 
dust. I could feel the sour throat for days after being exposed to the NRC.  
 
                                                 
19 Half-mask – a semi-protective mask, which has a filter for particles and covers the mouth and nose.  
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When NRC dust is inhaled it gives irritations in the upper respiratory tract, as 70-90% of 
the particles, which are larger than 10 µm in aerodynamic diameter, are deposited before 
the inhaled air reaches the larynx. [8] The employees in the production room are exposed 
to the irritating NRC and the other dusty compounds, which the Nicorette gum consists 
of. In the study of the irritation of the NRC, the results from when irritation was noticed, 
with sampling times lower than 4 minutes were studied extra carefully, it can be seen that 
there is a tendency that the tolerance to the NRC dust has increased during the day. For 
the day-to-day level of irritation, no trend could be detected whether the level was raised 
or not. When irritation from the NRC starts to be noticed, the concentration of nicotine 
from the air samples has been measured to a range of 2.5 to 120 µg/m3, which is equal to 
a range of NRC of 13 to 600 µg/m3. 
 
The symptoms of irritation start when the NRC is handled. The other Nicorette gum 
ingredients that dusts do not give irritations when they are handled separately from the 
NRC.  
 
The NRC samplings, whose results are presented in chapter D.4.3, have been done with 
very different sampling times (chapter D.4.3). Therefore there are risks of errors in the 
results. The short times of sampling have less chance to show the right concentration in 
the air of the measured substance. In this study just a very small volume of the filtered air 
containing NRC, from the mixing room, was sampled and analyzed.  
 
E.5 Methods  
The recovery of the method extracting the nicotine from the Teflon filters to ammonia 
hydroxide and the following liquid-to-liquid extraction to ethyl acetate was not 
calculated. The results in the Nicorette gum part must therefore be studied with criticism.   
 
The limits of detection for the analytical series were not established. Instead they were 
estimated, due to the calibration standard series for each of the analytical series. The limit 
of detection at 10 ng/ml for nicotine vapor, gives a possibility to measure concentrations 
of nicotine in the air at 1 µg/m3 when sampling for 10 minutes at a sampling rate of 2 
liters per minute. For four hours of sampling at a sampling rate of 1 liter per minute, 
concentrations of nicotine vapor in the air that can be detected can be as low as 0.1 
µg/m3. For the NRC the limit of detection is estimated to 10 ng/ml as well. 
Concentrations of nicotine from the NRC that are sampled in the air at a rate of 2 liters 
per minute can be detected at 0.8 µg/m3, which equals 4 µg/m3 of NRC.  For four hours 
of sampling, 0.1 µg/m3 of nicotine extracted from the NRC sampled in the air is 
detectable, a concentration of nicotine that equals 0.5 µg/m3 of NRC. 
 
Analyses of nicotine from the air samples taken in the Nicorette production were run and 
carry over effects could be observed when samples with a large concentration of nicotine 
were found. Carry over effects could be seen when samples with very low concentrations 
were run directly after those with large concentrations. Consequently it was difficult, 
sometimes impossible, to evaluate the right concentration in the sample with a low 
concentration. The carry over effects were between one and two percent of the 
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concentrations of the samples. To examine the magnitude of the carry over effect, 
samples with a high concentration of nicotine were run with more than one blank 
afterwards. The nicotine-containing samples gave the carry over effect from the nicotine, 
mentioned above, in the blank samples.  
 
In the Nicorette patch sample analysis, the first layer (A) was run prior to the second 
layer (B). Generally layer A contained a high concentration of nicotine. Layer B had less 
concentration, around 5 percent of that of A. After layer B had been analyzed, the process 
was repeated, starting with layer A from another XAD-2 tube. The carry over effect from 
layer A was not excluded in the calculation of the contents of nicotine in the XAD-2 tube. 
Carry over effects from layer B that were analyzed in the run before were negligible to 
the concentration of nicotine in the second sample of layer A.   
 
In the air samples from the Nicorette gum production concentrations of nicotine were 
very low in some samples. First all samples from the Teflon filters were run one after the 
other. Carry over effects did definitely influence the results when the concentrations were 
low. Therefore the samples with low concentration were run again with blanks (only the 
organic mobile phase - methanol) in between. The concentrations of the samples were 
then correctly analyzed.  
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F Conclusions 
 
According to the comparison between the exposure to nicotine from the air in the 
Nicorette patch production and the concentration of cotinine, in a few cases the cotinine 
content in the urine was higher than the potential exposure to the nicotine vapor in the 
surrounding air. That extra exposure might come from more than one source of exposure, 
probably from when the patches are handled, in combination with the negligence of not 
changing the gloves often enough. Or, when those tasks are performed using just one 
single pair of gloves instead of the double layer of gloves, which are supposed to be used. 
 
In the Nicorette gum production, the employees’ concentration of cotinine in the 
specimens of urine correlated to the exposure to nicotine from the NRC in the air shows a 
different relation than the one in the Nicorette patch production. The use of a protection 
mask may prevent the airborne NRC to reach the respiratory tract and the exposure to the 
NRC, and nicotine, is reduced.  
 
In order to estimate the accurate irritation level of the NRC more studies must be done 
with more participants included. A Short Time Exposure Limit (STEL) of NRC in air 
must be considered to be established, that STEL should be 100 µg/m3. Until then a TLV 
for Nicotine Resin Complex 20% IRP is considered to be as low as 100 µg/m3. 
 
The methods of extracting the nicotine from the Teflon filters and the liquid-to-liquid 
extraction must be validated before any final conclusions of the exposure to the NRC in 
the air can be affirmed.   
 
The method of using the concentration of nicotine in the ambient air, in the Nicorette 
patch and the Nicorette gum production rooms, to calculate the total exposure is not 
reliable. The concentration of urinary cotinine varied very much in relation to the amount 
of nicotine that the employees were exposed to from the air in the coating room. In the 
Nicorette gum production there were also very large variations between the concentration 
of cotinine of the employees and their exposure to nicotine, from the NRC in the 
surrounding air.  
 
To reduce the exposure in the Nicorette patch production even more, the design of the 
Mark Andy can be improved. More air extraction parts can be applied to the area where 
the Nicorette patches arrive at the reception position. At the reception, the patches could 
automatically be stacked together instead of making the two extra steps to collect them in 
stacks, by an employee and, move them over to the bench where they are wrapped in 
aluminum foil, by hand.  
 
For the employees at the Nicorette gum production, the exposure to NRC (nicotine) has 
been reduced over the years. New solutions, like the glove box, where NRC is filled into 
the container, and the more airtight joint, between the premix container and the tube in 
the floor, have reduced the exposure of NRC (nicotine) at the Nicorette gum production. 
Even less exposure may be possible to achieve, if all the production directions would be 
followed. A more airtight glove box cupboard would reduce the exposure too.  
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Abbreviations 
 
amu  - Atomic mass unit 
HPLC / LC - High performance liquid chromatography 
IS  - Internal standard 
m/z  - Mass over charge 
M  -  Molar (mol per liter) 
MS  -  Mass spectrometry 
MS/MS - Tandem mass spectrometry 
NRC   -  Nicotine Resin Complex 20% IRP  
rpm   - Rotations per minute 
STEL  - Short Time Exposure Limit 
TLV  - Threshold Limit Value 
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Appendix 1  Exposure to nicotine and urinary cotinine  
 
Table A.1.1: Exposure to nicotine from the air during the Nicorette patch production, urinary cotinine 
from the employees. 
 
Employee 
and day of 
sampling 
Concetration of 
nicotine in the air 
µg/m3
Time  
min 
Nicotine 
exposure 
µg*h/m3
Cotinine 
ng/ml 
Cotinine µmol 
/Creatinine mol 
1.0 - - - 0.4 0.3 
1.1* 7.7 330 43 7.3 4.1 
1.2* 10 260 46 10 6.7 
1.3* 12 280 53 12 9.1 
1.4* 13 270 57 14 11 
2.0 - - - 6.1 2.0 
2.1 23 280 110 14 5.3 
2.2 20 270 92 13 6.2 
2.3 20 230 77 13 4.7 
3.0 - - - 14 3.3 
3.1 15 190 49 21 7.4 
4.0 - - - 3.9 1.5 
4.1* 8.6 270 39 15 4.5 
4.2* 14 320 73 22 11 
4.3* 19 350 110 18 9.5 
4.4* 11 270 50 17 8.7 
4.5* 14 210 48 13 8.8 
5.0 - - - 3.2 1.4 
5.1* 25 200 83 13 16 
6.0 - - - 0.4 0.3 
6.1 17 280 82 6.4 2.5 
7.0** - - - 20 7.3 
7.1 8.6 250 37 29 6.3 
7.2 16 300 82 35 7.3 
7.3 23 260 98 30 7.4 
7.4 21 260 88 22 8.1 
7.5 9.4 220 34 10 2.6 
8.0** - - - 290 190 
8.1 7.0 150 17 110 37 
8.2 21 320 106 180 54 
8.3 23 280 107 95 33 
8.4 24 270 109 52 20 
9.0** - - - 990 840 
9.1 23 250 97 1100 1100 
9.2 26 210 90 1100 1500 
9.3 18 330 99 460 420 
9.4 17 250 73 580 680 
 
* The employee did not use a double layer of protection gloves during production. 
** The employee’s zero value of urinary cotinine is very high. The sampled specimens of 
urine the days after the exposure to nicotine in the production cannot be used. 
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Table A.1.2: Urinary cotinine from the employees in the Nicorette gum production, the exposure to 
nicotine from the NRC in the air and a value of nicotine exposure that can give the concentration of 
cotinine in the urine sampled. 
 
Employee 
and day of 
sampling  
Concetration of 
nicotine from  
NRC in the air  
µg/m3
Time  
min 
Nicotine 
exposure 
µg*h/m3
Cotinine 
ng/ml 
Cotinine µmol 
/Creatinine mol 
1.0 - - - 11 4.1 
1.1* 17 270 78 28 12 
1.2* 82 130 170 34 10 
1.3* 24 55 22 30 9.7 
2.0 - - - 2.1 0.9 
2.1* 38 120 78 7.0 1.7 
3.0 - - - 2.8 1.7 
3.1* 13 300 62 13 3.2 
4.0 - - - 5.4 2.8 
4.1* 43 29 21 7.2 4.4 
5.0 - - - 1.2 0.5 
5.1** 76 250 310 19 5.2 
6.0 - - - 2.5 0.5 
6.1* 15 220 54 11 2.4 
7.0 - - - 0.6 0.8 
7.1* 5.8 210 20 5.4 2.6 
 
* The employee used a mask while filling the NRC into the containers. 
** The employee used a half-mask when filling the NRC, during the other part of the 
time inside the mixing room no mask was used at all. 
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Appendix 2  Material  
2.1 Air sampling 
Filter:  Gelman Sciences, Teflon TF 1000, diameter 37 mm, pore 
size 1 µm  
Filter cassettes:  Omega Specialty Instruments Co., filter cassettes 37 mm  
Plastic hose:   Latex tubing, Amber, VWR Scientific 
Pump:     MSA, Escort ELF Pump, Aver 
    SKC, Aircheck sampler model 224-52 
XAD-2 tubes:   SKC Tube Xad-2 
 
2.2 Sample extraction and preparation 
Centrifuge:    Sigma 3E 1  
Evaporator:   SPD 2010 Termo Savant 
Refractometer:  Hand Refractometer, Ladassco ATAGO 
Shaker:    Ika - Vibrax – VXR electronic 
  
2.3 Chemicals 
Ammonia solution 25%  Merck Eurolab AB 
Ammonium acetate   Merck Eurolab AB  
Cotinine,    Sigma Chemical Co. 
D3-cotinine    Sigma Chemical Co. 
Ethyl acetate    Lab-Scan Analytical Sciences  
Methanol    Lab-Scan Analytical Sciences 
Nicotine    Janssen Chimica 
D3-Nicotine    Lab-Scan Analytical Sciences 
Potassium hydroxide   Merck Eurolab AB 
Water     H2O-MilliQ at 18.2 MΩ 
 
2.4 Analysis 
LC-MS/MS: Perkin-Elmer Biosystems, PE SCIEX API 3000, 
LC/MS/MS System    
Triple quadrupole LC-MS/MS mass spectrometer 
    PE 200 Autosampler 
    PE 200 Micropump 
Software Version:  Analyst 1.4 
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Appendix 3  Chemical and physical data, classification and toxicological 
information 
3.1 Chemical and physical data 
3.1.1 Nicotine [5] 
Synonym:   3-(2(N-methylpyrrolidinyl))pyridine 
Molecular formula:  C10H14N2
CAS-number:   54-11-5 
Molecular weight:  162.2 g/mol 
Appearance: Oily, colorless hygroscopic liquid,  
turns brown on exposure to air.  
Sticky, characteristic odor.  
Boling point:   247°C 
Melting point:   -80°C      Nicotine 
Density:   1.01 g/cm3
pKa1:    7.84 at 25°C 
pKa2:    3.04 at 25°C 
Octanol/water partition  
coefficient: log Pow:  1.2 
Vapor pressure (20°C): 0.006 kPa  
 
3.1.2 Nicotine Resin Complex 20% IRP [15] 
Synonym:   Nicotine Polacrilex 
Molecular formula: Amberlite IRP64 Resin  
(Divinylbenzene/methacrylic  
acid copolymer) (C18O4H22)n
    Nicotine C10H14N2 
CAS-number:   96055-45-7 
Appearance:   White, dusty powder.  
Boling point:   Not applicable  
Melting point:   No data available 
Density:   0.4 g/cm3
Octanol/water partition  
coefficient: log Pow:  No data available 
         Amberlite IRP64 Resin 
*
*
*
*
OH
OH
O
O
n
 
3.2 Classification 
3.2.1 Nicotine [5] 
Classification:   T+  Very toxic 
    N  Dangerous for the environment. 
R-phrases:     R 26/27/28 Very toxic by inhalation, in contact with the 
skin or swallowed. 
    R 36/37 Irritating to eyes and respiratory system. 
R 51/53 Toxic to aquatic organisms, may cause long-
term adverse effects in the aquatic 
environment. 
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S-phrases:  S 36/37 Wear suitable protective clothing and gloves 
S 38 In case of insufficient ventilation, wear 
suitable respiratory equipment. 
S 45 In case of accident or if you feel unwell, 
seek medical advice immediately (show the 
label if possible). 
S 61 Avoid release of the substance to the 
environment. Refer to special 
instructions/Safety data sheets. 
Exposure Limit Values: ACGIH TLV (1992 – 1993): 0.5 mg/m3 (TWA20) Skin 
 
 
3.2.2 Nicotine Resin Complex 20% IRP [5] 
Principal Hazardous  
component:  Nicotine Resin Complex 20% IRP (NRC) is a compound of 
20% nicotine in an ion-exchange resin. The nicotine will 
release in contact with perspiration or saliva.  
Classification:   Same as for nicotine. 
R-phrases:   Same as for nicotine. 
S-phrases:   Same as for nicotine. 
Exposure Limit Values: Same as for nicotine. 
 
3.3 Toxicological information 
3.3.1 Nicotine [5] 
LD50 (oral rat):  50 mg/kg 
Mutagenicity:   Negative in Ames’ test 
 
3.3.2 Amberlite IRP64 Resin [16] 
LD50 (oral rat):  >5000 mg/kg 
Mutagenicity:   Negative in Ames’ test 
Particle size:   5 % > 710 µm 
85 % < 212 µm 
100 % > 1 µm [17] 
                                                 
20 TWA –Time weighted Average for an 8 hours working day. 
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Appendix 4  Mass spectrometric settings 
4.1 Nicotine 
HPLC-column: Agilent Technologies, Zorbax Extend-C18, 2.1 * 50 mm, 
3.5 µm 
Mobile phase:   10 mM ammonia acetate pH 9.5 (A), methanol (B) 
Ionization:   Electrospray, interface (setpoint) temperature 360°C 
 
Injection details 
Syringe Size: 250 µl 
Injection Volume: 3 µl 
 
Flush details 
Pre-inject Flushes: 2 
Post-inject Flushes: 2 
 
 
Table A.4.1: Step table. 
 
Step Total time min Flow rate µl/min Gradient profile A % B % 
0 0.0 500 1 99 1 
1 1.0 500 1 99 1 
2 1.1 500 1 5 95 
3 2.2 500 1 5 95 
4 2.3 500 1 99 1 
5 4.0 500 1 99 1 
 
Table A.4.2: Fragmentation table. 
 
Q1 amu Q3 amu Dwell ms 
162.9 130.1 50 
162.9 84.3 50 
166.0 87.3 50 
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4.2 Cotinine 
HPLC-column:   Agilent Technologies, Zorbax C18, 4.5 * 50 mm, 5 µm 
Mobile phase:   10 mM ammonia acetate (A), methanol (B) 
Ionization:   Electrospray, interface (setpoint) temperature 450°C 
 
Inject details 
Syringe Size: 250 µl 
Injection Volume: 5 µ
 
Flush details 
Pre-inject Flushes: 1 
Post-inject Flushes: 1 
 
Table A.4.3: Step table.  
 
Step Total time min Flow rate µl/min G file A % B % 
0 0.0 700 1 95 5 
1 4.0 700 1 5 95 
2 4.1 700 1 95 5 
3 6.0 700 1 95 5 
 
 
Table A.4.4: Fragmentation table. 
 
Q1 amu Q3 amu Dwell ms 
179.9 80.3 50 
177.0 80.1 50 
177.0 98.2 50 
 
 50radient prol 
Appendix 5  Maps of Nicorette production rooms with sampling 
positions 
5.1 Nicorette patch production room – the coating room 
An overall ventilation runs all the time and three large air extraction regulators are 
installed there, one above the reception position, another one in the center of the room 
above the Mark Andy and a third one above where the liqud nicotine is. 
~ 6 m 
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Figure A.5.1: Map of the coating room for the Nicorette patch production. 
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5.2 Nicorette gum production room – the mixing room 
An overall ventilation runs all the time and two air extraction regulators are situated in 
the ceiling in the center of the room, one above the glove box and one above the cylinder 
in the right corner of the sketch.   ~ 6 m 
D
oo
r 
Door A central vacuum cleaner, to the premix 
container can be attached to this air extraction
Premix container 
Glove box with perforated 
air extracted bench 
including the sieve where 
NRC is filled 
ME 
D
oo
r 
Tube to the floor 
downstairs where all 
the NRC ingredients 
are mixed together 
~ 
9 
m
 
Persoal 
sampler 
Stationary 
sampler 
Point air 
extraction
Central vacuum 
cleaner  
 
Figure A.5.2: Map of the Nicorette gum production room, the mixing room. 
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Appendix 6  Calculations 
 
1 Concentration of nicotine in Nicorette patch production 
 
2 [ml] * ((Alayer + Blayer)[ng/ml]) / (sampled volume [m3] * 1000) = [µg/m3] 
 
 
2 Concentration of nicotine in Nicorette gum production 
 
3[ml]/2 * (filter content [ng/ml]) / (sampled volume [m3] * 1000) = [µg/m3] 
 
 
3 Exposure to nicotine in the Nicorette patch and Nicorette gum production 
 
Concentration of nicotine [µg/m3] * Time for exposure [h] = [µg*h/m3] 
 
 
4 Urinary concentration of cotinine 
 
a) Correlated to creatinine: 
Concentration of cotinine [nmol]/concentration of creatinine [mmol] 
 
b) Correlated to urine density: 
(Concentration of cotinine [nmol/l]*0.024 [g/ml])/(urine density [g/ml] – 1) = [nmol/l] 
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